Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Journey Group Acquisition Co

Advertisement

Advertisement

3411 Silverside Rd
Wilmington, DE 19810

Journey Group Acquisition Co is a business based in Wilmington, DE that specializes in acquiring and managing a diverse portfolio of companies across various industries.

With a focus on strategic investments and growth opportunities, the company aims to drive value and foster long-term success for its acquired businesses.

Generated from their business information

Also at this address

Rehabilitation Consultants Inc

Affiliate Relations Holdings

La Floresta Perdida Inc

Oppenheimer Trust Co-Delaware

Find related places

Financial Advisor

Financial Advisor

Own this business?
Claim it
See a problem?

You might also like

Business services, nec, nec

MDR Corp

MDR Corp, based in Wilmington, DE, is a web design studio specializing in custom website development and mobile apps since 1995. Their team of talented graphic designers and developers have created exceptional digital experiences for top businesses and organizations in Delaware and the Mid-Atlantic region. With a focus on design excellence, technical expertise, and value, MDR Corp offers expert programming, digital marketing, and ongoing support to ensure clients receive spectacular projects that exceed expectations. Their commitment to exceptional service and delivering high-end creative solutions sets them apart as a trusted partner for building engaging online experiences. Generated from the website

Horizon Acquisitions LLC

Horizon Acquisitions LLC is a strategic investment firm based in Wilmington, DE, specializing in identifying and acquiring promising businesses across various industries. With a focus on long-term growth and value creation, the company leverages its expertise to support and enhance the operations of its portfolio companies. Generated from their business information

NRX Pharmaceuticals, Inc

NRx Pharmaceuticals, Inc. is a pharmaceutical company based in Wilmington, DE that focuses on developing breakthrough medicines for individuals suffering from life-threatening conditions such as bipolar depression, post-traumatic stress disorder (PTSD), chronic pain, and suicidal ideation. Their lead candidate, NRX-101, is the first oral medication currently undergoing FDA trials for suicidal bipolar depression, offering hope to those in need of effective treatment options. With a strong emphasis on scientific research and clinical approach, NRx Pharmaceuticals aims to address the urgent need for non-addictive and non-sedating pain medication in light of the ongoing opioid crisis. Their commitment to innovation and development is evident through their collaborations with Lotus Pharmaceuticals and Alvogen Inc. to commercialize NRX-101, as well as their FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for the treatment of complicated urinary tract infections and pyelonephritis.Generated from the website
United States›Delaware›Wilmington›Journey Group Acquisition Co

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell